Claims for Patent: 8,044,046
✉ Email this page to a colleague
Summary for Patent: 8,044,046
| Title: | Medicaments for the treatment of chronic obstructive pulmonary disease |
| Abstract: | A pharmaceutical composition comprising a compound of formula 1 ##STR00001## wherein: n is 1 or 2; R.sup.1 is hydrogen, C.sub.1-C.sub.4-alkyl, halogen, OH, or --O--C.sub.1-C.sub.4-alkyl; R.sup.2 is hydrogen, C.sub.1-C.sub.4-alkyl, halogen, OH, or --O--C.sub.1-C.sub.4-alkyl; R.sup.3 is hydrogen, C.sub.1-C.sub.4-alkyl, OH, halogen, --O--C.sub.1-C.sub.4-alkyl, --O--C.sub.1-C.sub.4-alkylene-COOH, or --O--C.sub.1-C.sub.4-alkylene-CO--O--C.sub.1-C.sub.4-alkyl, or an acid addition salt thereof with a pharmacologically acceptable acid, or a solvate or hydrate thereof; and a pharmaceutically acceptable excipient or carrier, and methods for using the pharmaceutical formulation in the treatment of chronic obstructive pulmonary disease (COPD). |
| Inventor(s): | Konetzki; Ingo (Warthausen, DE), Schromm; Kurt (Ingelheim am Rhein, DE), Schollenberger; Hermann (Ingelheim am Rhein, DE), Pestel; Sabine (Attenweiler, DE), Schnapp; Andreas (Biberach, DE), Bouyssou; Thierry (Warthausen, DE), Buettner; Frank (Attenweiler, DE), Heine; Claudia (Biberach, DE), Lustenberger; Philipp (Basel, CH), Hoenke; Christoph (Ingelheim, DE), Rudolf; Klaus (Warthausen, DE) |
| Assignee: | Boehringer Ingelheim Pharma GmbH & Co KG (Ingelheim, DE) |
| Application Number: | 11/132,075 |
| Patent Claims: |
1. A method for the treatment of Chronic Obstructive Pulmonary Disease (COPD) comprising administration of a therapeutically effective amount of
R-6-Hydroxy-8-{1-hydroxy-2[2-(4-methoxy-phenyl)-1,1-dimethyl-ethylamino]-- ethyl}-4H-benzo[1,4]oxazin-3-one, or an acid addition salt thereof with a pharmacologically acceptable acid; and a pharmaceutically acceptable excipient or carrier.
2. A method for the treatment of Chronic Obstructive Pulmonary Disease (COPD) comprising administration of a therapeutically effective amount of R-8-{2-[2-(2,4-difluorophenyl)-1,1-dimethyl-ethylamino]-1-hydroxy-ethyl}-- 6-hydroxy-4H-benzo[1,4]oxazin-3-one, or an acid addition salt thereof with a pharmacologically acceptable acid; and a pharmaceutically acceptable excipient or carrier. 3. A method for the treatment of Chronic Obstructive Pulmonary Disease (COPD) comprising administration of a therapeutically effective amount of R-8-{2-[2-(3,5-difluorophenyl)-1,1-dimethyl-ethylamino]-1-hydroxy-ethyl}-- 6-hydroxy-4H-benzo[1,4]oxazin-3-one, or an acid addition salt thereof with a pharmacologically acceptable acid; and a pharmaceutically acceptable excipient or carrier. 4. A method for the treatment of Chronic Obstructive Pulmonary Disease (COPD) comprising administration of a therapeutically effective amount of R-8-{2-[2-(4-Ethoxy-phenyl)-1,1-dimethyl-ethylamino]-1-hydroxy-ethyl}-6-h- ydroxy-4H-benzo[1,4]oxazin-3-one, or an acid addition salt thereof with a pharmacologically acceptable acid; and a pharmaceutically acceptable excipient or carrier. 5. A method for the treatment of Chronic Obstructive Pulmonary Disease (COPD) comprising administration of a therapeutically effective amount of R-8-{2-[2-(4-fluorophenyl)-1,1-dimethyl-ethylamino]-1-hydroxy-ethyl}-6-hy- droxy-4H-benzo[1,4]oxazin-3-one, or an acid addition salt thereof with a pharmacologically acceptable acid; and a pharmaceutically acceptable excipient or carrier. |
